Ligature Therapeutics Launches, Raises USD $6M in Seed Financing
SINGAPORE, Jan 5 (Bernama-GLOBE NEWSWIRE) — Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has announced the close of USD $6 Million in seed round funding. The financing, led by Lightstone Ventures, with the participation of Enterprise Singapore’s investment arm, SEEDS Capital, will be used…

